Novel Applications for Topical Agents in the Management of Pain
Highlights from the 22nd Annual Scientific Meeting of the American Pain Society
Activity Date: July 2003  — Activity Info: Volume 3, (7A)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity


Full Disclosure Policy Affecting CME Activities:
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Program Directors and Participating Faculty reported the following:


    Peter Staats, MD
    Department of Anesthesiology and Critical Care Medicine
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Staats reports receiving grant and/or research support from the American Neuromodulation Society, Elan Corporation, and Medtronic; and serving as a consultant to the American Neuromodulation Society, Elan Corporation, Johnson & Johnson, Medtronic, and Pfizer, Inc.


    Charles E. Argoff, MD
    Director, Cohn Pain Management Center
    North Shore University Hospital
    Bethpage, New York
    Assistant Professor of Neurology
    New York University School of Medicine
    New York, New York
    • Dr Argoff reports receiving grant and/or research support from, serving as a consultant to, and receiving honoraria from Allergan, Inc, Elan Corporation, Endo Pharmaceuticals, GlaxoSmithKline, and Pfizer, Inc.

    Gary McCleane, MD
    Consultant in Pain Management
    Rampark Pain Centre
    Lurgan, N Ireland
    United Kingdom
    • Dr McCleane reports having no financial or advisory relationships with corporate organizations related to this activity.

    Jana Sawynok, PhD
    Professor of Pharmacology
    Department of Pharmacology
    Dalhousie University
    Halifax, Nova Scotia
    • Dr Sawynok reports receiving grants and/or research support from Epicept Corporation.

In accordance with the ACCME Standards for Commercial Support, the audience is advised that one or more articles in this continuing medical education activity contains reference(s) to unlabeled or unapproved uses of drugs or devices. The following faculty member has disclosed that his article has referenced the following unlabeled/unapproved uses of drugs or products:

Dr Argoff - amitriptyline, doxepin, lidocaine patch 5%
Dr McCleane - nitrates, tricyclic antidepressants
All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

Home | Contact Us | View Account | Need Help?